Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method for treating Huntington's disease using glial cell line-derived neurotrophic factor (GDNF) protein product

US Patent 5741778 · Granted Apr 21, 1998

Estimated economic value: $55,467,000

Assignee

Inventors

View full patent text on Google Patents →